Conclusion
Tenofovir is a drug that is suspected less as a culprit drug during
cutaneous eruptions as there are only limited reported cases.
Tenofovir-induced LCV has been reported in 2 cases before this case
report. Though cutaneous vasculitis is a less common adverse effect due
to tenofovir, clinicians should be aware of this because timely
diagnosis helps in the proper management of the patient.